IL17A and psoriasis: Mast-cell-derived IL-17 has been investigated in several autoimmune diseases, including rheumatoid arthritis [13], psoriasis [26], and spondylarthritis [27], in which mast cells were a major cellular source of IL-17, and showed a strong correlation with pathogenesis and disease progression.